This podcast gives you a five minute overview of the 3rd annual Clinical Trial Collaborations conference, otherwise known as CTC.
CTC is a strategic level event focused on arguably the most important change in transforming drug development: How and who we collaborate with to drive better clinical trial outcomes?
CTC is ideal for people working in clinical trial operations, who are involved with external relationships or need to be involved with external relationships and want to see examples of strategic and creative solutions to successful collaborations and who we need to be collaborating with next?
The program takes place on April 9th – 11th at the Boston Marriott Cambridge and is divided into three parts, one on each day of the event. Part I deals with new advancements in clinical trial collaborations, current examples to challenge us, and progress. Part II focuses on strategic collaborations, virtual trials and next generation monitoring. Part III addresses how do we bring clinical research closer to patients and vice versa.
CTC is co-chaired by Ken Getz, Director of Sponsored Research, Tufts CSDD, Murray Abramson, MD, VP, Clinical Operations, Biogen, Jeff James, CEO, Wilmington Health and Katherine Vandebelt, Chief Ecosystem Officer, Reify Health.
Use code TEML for 10% off and for more information visit, www.theconferenceforum.org.